eBooks & Guides

The biologics researcher's guide to DLS

Issue link: https://resources.nanotempertech.com/i/1393304

Contents of this Issue

Navigation

Page 6 of 63

7 Biologics are drugs and treatments that derive from molecules created in cells. What are Biologics? Biologics also include other protein-based treatments. Enzymatic proteins are used for treatment of certain disorders, such as insulin in the case of diabetes, or asparaginase for leukemia. They might also refer to biological components used in pharmaceutical development, such as antigens developed as vaccine targets. Finally, it's important to note that biologics are not limited to proteins. One example is gene therapy, where viral vectors deliver DNA or RNA to specific cell types with the aim to treat a wide range of diseases and disorders, including hemophilia and muscular dystrophy. Natural products derived from cells are another type of non-protein biologic. A popular example of this is Botox, a toxin derived from Clostridium botulinum. Some of the most common biologics treatments are antibodies – Humira (adalimumab) for autoimmune diseases or Herceptin (trastuzumab) for breast cancer are name brands that even non-researchers recognize. While monoclonal antibodies (mAb) are still the mainstay of the biologics industry, they are being engineered for higher potency and novel mechanisms of action in the forms of antibody-drug conjugates (ADCs) and bi-specific antibody derivatives.

Articles in this issue

view archives of eBooks & Guides - The biologics researcher's guide to DLS